glucuronic acid has been researched along with verapamil in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 4 (57.14) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bosslet, K; Czech, J; Desbene, S; Florent, JC; Gerken, M; Koch, M; Michel, S; Monneret, C; Schmidt, F; Straub, R; Tillequin, F; Van, HD | 1 |
| Aminabhavi, TM; Kariduraganavar, MY; Kulkarni, AR; Kurkuri, MD | 1 |
| Bouropoulos, N; Pasparakis, G | 1 |
| Farhana, SA; Narasu, L; Shalam, M; Shantakumar, SM; Shyale, S | 1 |
| Al-Zoubi, NM; AlKhatib, HS; Obeidat, WM | 1 |
| Farkas, I; Marosi, G; Nagy, Z; Pataki, H; Vajna, B | 1 |
| Abdel-Rahim, S; Al-Zoubi, N; Alkhatib, HS; Alobaidi, G; Malamataris, S; Obeidat, W | 1 |
7 other study(ies) available for glucuronic acid and verapamil
| Article | Year |
|---|---|
Application of the ADEPT strategy to the MDR resistance in cancer chemotherapy.
Topics: Animals; Antineoplastic Agents; Chromatography, High Pressure Liquid; Dipyridamole; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Drug Stability; Escherichia coli; Glucuronates; Glucuronic Acid; Glucuronidase; Humans; Hydrolysis; Leukemia L1210; Prodrugs; Quinine; Spectrophotometry, Ultraviolet; Structure-Activity Relationship; Tumor Cells, Cultured; Verapamil | 1999 |
In vitro release study of verapamil hydrochloride through sodium alginate interpenetrating monolithic membranes.
Topics: Alginates; Calcium Channel Blockers; Calorimetry, Differential Scanning; Diffusion; Drug Carriers; Glucuronic Acid; Hexuronic Acids; Kinetics; Membranes, Artificial; Permeability; Spectroscopy, Fourier Transform Infrared; Time Factors; Verapamil | 2001 |
Swelling studies and in vitro release of verapamil from calcium alginate and calcium alginate-chitosan beads.
Topics: Alginates; Anti-Arrhythmia Agents; Buffers; Chitosan; Delayed-Action Preparations; Drug Carriers; Glucuronic Acid; Hexuronic Acids; Hydrochloric Acid; Microscopy, Electron, Scanning; Particle Size; Spectroscopy, Fourier Transform Infrared; Verapamil; Water | 2006 |
Sustained release of verapamil hydrochloride from sodium alginate microcapsules.
Topics: Alginates; Animals; Capsules; Delayed-Action Preparations; Drug Compounding; Drug Stability; Glucuronic Acid; Hexuronic Acids; Male; Models, Statistical; Particle Size; Polymers; Rabbits; Rheology; Solubility; Surface Properties; Verapamil | 2010 |
Evaluation of hydrophilic matrix tablets based on Carbopol(®) 971P and low-viscosity sodium alginate for pH-independent controlled drug release.
Topics: Acetaminophen; Acrylates; Alginates; Delayed-Action Preparations; Drug Compounding; Drug Delivery Systems; Glucuronic Acid; Hexuronic Acids; Humans; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; In Vitro Techniques; Microscopy, Electron, Scanning; Particle Size; Salicylic Acid; Tablets; Verapamil; Viscosity | 2011 |
Characterization of melt extruded and conventional Isoptin formulations using Raman chemical imaging and chemometrics.
Topics: Alginates; Delayed-Action Preparations; Ethanol; Excipients; Glucuronic Acid; Hexuronic Acids; Solubility; Solvents; Spectrum Analysis, Raman; Tablets; Technology, Pharmaceutical; Verapamil | 2011 |
Optimization of pH-independent chronotherapeutic release of verapamil HCl from three-layer matrix tablets.
Topics: Alginates; Chemistry, Pharmaceutical; Delayed-Action Preparations; Drug Chronotherapy; Drug Liberation; Glucuronic Acid; Hexuronic Acids; Hydrogen-Ion Concentration; Models, Statistical; Neural Networks, Computer; Polysaccharides, Bacterial; Tablets; Verapamil | 2015 |